KEMPHARM INC's ticker is and the CUSIP is 488445AB3. A total of 3 filers reported holding KEMPHARM INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $32,179,000 | +1.7% | 62,423,000 | -4.6% | 1.31% | +15.5% |
Q2 2019 | $31,632,000 | +10.3% | 65,423,000 | 0.0% | 1.14% | +3.3% |
Q1 2019 | $28,677,000 | -27.1% | 65,423,000 | 0.0% | 1.10% | -30.2% |
Q4 2018 | $39,363,000 | -18.5% | 65,423,000 | -12.8% | 1.58% | -8.8% |
Q3 2018 | $48,281,000 | -12.9% | 75,000,000 | 0.0% | 1.73% | -11.2% |
Q2 2018 | $55,438,000 | -3.2% | 75,000,000 | 0.0% | 1.95% | -1.9% |
Q1 2018 | $57,250,000 | +25.1% | 75,000,000 | 0.0% | 1.98% | +10.2% |
Q4 2017 | $45,750,000 | +0.1% | 75,000,000 | 0.0% | 1.80% | -12.5% |
Q3 2017 | $45,688,000 | +3.2% | 75,000,000 | 0.0% | 2.06% | -12.8% |
Q2 2017 | $44,250,000 | -3.2% | 75,000,000 | 0.0% | 2.36% | +33.9% |
Q1 2017 | $45,719,000 | – | 75,000,000 | – | 1.76% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 75,000,000 | $57,250,000 | 1.98% |
DSC Advisors, L.P. | 8,250,000 | $6,112,000 | 1.28% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 3,000,000 | $2,065,000 | 0.16% |